LISDEXAMFETAMINE IN CANADA: A COMPREHENSIVE GUIDE

Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in youngsters and individuals. In Canada, its distribution is overseen by Health Canada. This guide intends to offer understandable information on its therapeutic applications ,